Admin Core
管理核心
基本信息
- 批准号:10709003
- 负责人:
- 金额:$ 20.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-22 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesChargeCommunicationCytomegalovirusDatabasesDecision MakingEnsureFosteringGrantHIVHumanHuman ResourcesImmunologicsInstitutionLeadershipMaintenanceManuscriptsNational Institute of Allergy and Infectious DiseasePhaseProgram Research Project GrantsProgress ReportsQualifyingQuality ControlReportingSIV VaccinesScientific Advances and AccomplishmentsScientific EvaluationScientistStatistical Data InterpretationSupervisionTravelUnited States National Institutes of HealthVisitWritingclinical developmentcollaborative environmentdata curationdata sharingmeetingsprogramsresearch clinical testingsuccessvectorvector vaccinevideoconference
项目摘要
CORE A PROJECT SUMMARY
The purpose of Core A (Administrative Core) is to provide the organizational framework to optimally implement
the multi-project research program proposed in this Program Project application, a grant that seeks to understand
the unique “replication arrest” efficacy of 68-1 RhCMV-based Simian Immunodeficiency virus (SIV) vaccine
vectors as a guide to downstream clinical development of the Human Cytomegalovirus (HCMV)/ Human
Immunodeficiency virus (HIV) vectors that are currently in Phase 1 clinical testing. This framework will provide
scientific leadership and integration of the Program, as well as administrative support and assistance to the
Program Director and Project Leaders. This support and assistance includes providing logistical support on
administrative and clerical matters, facilitating interactions between Project and Core Leaders and providing a
forum for decision making, database maintenance and administration, data curation and sharing, experimental
planning, statistical analysis, regulatory compliance assistance, manuscript writing and submission, progress
report submission, and financial tracking and management, as well as organizing an external advisory committee
to evaluate the progress and overall direction of the program.
The specific aims of this Core are:
1. To ensure an interactive environment and foster a cohesive, focused relationship among Program scientists
and to provide a forum for Project and Core Leaders to set overall priorities and make key decisions via
regular meetings and videoconferences.
2. To promote scientific advancement of the Program by establishing an external advisory committee (EAC) to
review the progress of the program, and provide independent scientific and clinical development oversight.
3. To provide fiscal oversight and general administrative, budgetary, database, and statistical support for the
overall program,
4. To maintain communication with the NIAID program officer and other NIAID staff, coordinate reports to the
NIH and EAC and ensure compliance with NIH and local institutional requirements.
核心A项目总结
核心A(行政核心)的目的是提供组织框架,
本计划项目申请中提出的多项目研究计划,旨在了解
猴免疫缺陷病毒(SIV)68-1 RhCMV疫苗独特“复制阻滞”效应
载体作为人巨细胞病毒(HCMV)/人
免疫缺陷病毒(HIV)载体,目前处于第1阶段临床试验。该框架将提供
科学的领导和整合计划,以及行政支持和援助,
项目经理和项目领导人。这种支持和援助包括提供后勤支助,
行政和文书事务,促进项目和核心领导人之间的互动,并提供一个
决策论坛、数据库维护和管理、数据管理和共享、实验
规划、统计分析、法规遵从性协助、手稿撰写和提交、进展
报告提交、财务跟踪和管理,以及组织外部咨询委员会
评估项目的进展和总体方向。
该核心的具体目标是:
1.确保互动的环境,并在项目科学家之间培养有凝聚力、有重点的关系
并为项目和核心领导人提供一个论坛,以通过以下方式确定总体优先事项并做出关键决策
定期会议和视频会议。
2.通过建立外部咨询委员会(EAC)促进该计划的科学进步,
审查项目的进展,并提供独立的科学和临床开发监督。
3.提供财政监督和一般行政,预算,数据库和统计支持,
总体方案,
4.保持与NIAID项目官员和其他NIAID工作人员的沟通,协调报告,
NIH和EAC,并确保符合NIH和当地机构的要求。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Louis J. Picker其他文献
760. Overcoming Rhesus Macaque Endogenous Restriction Factors during HIV-1 Vector Transduction
- DOI:
10.1016/j.ymthe.2006.08.844 - 发表时间:
2006-01-01 - 期刊:
- 影响因子:
- 作者:
Christina H. Swan;Udayan Chatterji;Philippe Gallay;Louis J. Picker;Bruce E. Torbett - 通讯作者:
Bruce E. Torbett
Pulmonary Artery-Bronchial Fistula Complicating Chronic Lymphocytic Leukemia
- DOI:
10.1378/chest.86.1.134 - 发表时间:
1984-07-01 - 期刊:
- 影响因子:
- 作者:
James K. Stoller;Louis J. Picker;Scott T. Weiss;Robert L. Thurer;Earl J. Kasdon - 通讯作者:
Earl J. Kasdon
Antibodies advance the search for a cure
抗体推动了对治愈方法的探索
- DOI:
10.1038/nature12703 - 发表时间:
2013-10-30 - 期刊:
- 影响因子:48.500
- 作者:
Louis J. Picker;Steven G. Deeks - 通讯作者:
Steven G. Deeks
Seeking ultimate victory
追求最终的胜利
- DOI:
10.1038/nature14194 - 发表时间:
2015-01-07 - 期刊:
- 影响因子:48.500
- 作者:
Louis J. Picker;Jeffrey D. Lifson - 通讯作者:
Jeffrey D. Lifson
Programming cytomegalovirus as an HIV vaccine
将巨细胞病毒编程为一种 HIV 疫苗
- DOI:
10.1016/j.it.2023.02.001 - 发表时间:
2023-04-01 - 期刊:
- 影响因子:13.900
- 作者:
Louis J. Picker;Jeffrey D. Lifson;Michael Gale;Scott G. Hansen;Klaus Früh - 通讯作者:
Klaus Früh
Louis J. Picker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Louis J. Picker', 18)}}的其他基金
Project 1: Systemic analysis of the origin and tissue effects of the 68-1 RhCMV/SIV vaccine efficacy-predictive whole blood transcriptomic signature
项目1:68-1 RhCMV/SIV疫苗功效预测全血转录组特征的起源和组织效应的系统分析
- 批准号:
10723639 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
RhCMV/SIV 疫苗诱导复制抑制功效的免疫学和病毒学基础
- 批准号:
10619297 - 财政年份:2022
- 资助金额:
$ 20.17万 - 项目类别:
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
项目 3:确定 RhCMV/SIV 疫苗介导的 SIV 复制抑制功效所需的最小 MHC-E 限制性 SIV 表位靶向
- 批准号:
10709020 - 财政年份:2022
- 资助金额:
$ 20.17万 - 项目类别:
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
RhCMV/SIV 疫苗诱导复制抑制功效的免疫学和病毒学基础
- 批准号:
10709002 - 财政年份:2022
- 资助金额:
$ 20.17万 - 项目类别:
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
项目 3:确定 RhCMV/SIV 疫苗介导的 SIV 复制抑制功效所需的最小 MHC-E 限制性 SIV 表位靶向
- 批准号:
10619304 - 财政年份:2022
- 资助金额:
$ 20.17万 - 项目类别:
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
用于 HIV/AIDS 疫苗的免疫原性和功效优化的 CMV 载体的开发
- 批准号:
9883700 - 财政年份:2017
- 资助金额:
$ 20.17万 - 项目类别:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
安全性增强的 RhCMV/SIV 载体的开发和体内表征
- 批准号:
8227957 - 财政年份:2011
- 资助金额:
$ 20.17万 - 项目类别:
ROLE OF MEMORY T CELL DYNAMICS IN SIV INFECTION
记忆 T 细胞动力学在 SIV 感染中的作用
- 批准号:
8357743 - 财政年份:2011
- 资助金额:
$ 20.17万 - 项目类别:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
安全性增强的 RhCMV/SIV 载体的开发和体内表征
- 批准号:
8416334 - 财政年份:2011
- 资助金额:
$ 20.17万 - 项目类别:
相似国自然基金
CHARGE综合征致病基因CHD7介导的三维转录调控网络研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
Sema3E在CHARGE综合症中的作用及机制研究
- 批准号:81160144
- 批准年份:2011
- 资助金额:52.0 万元
- 项目类别:地区科学基金项目
相似海外基金
CAS: Proton-Coupled Electron Transfer Reactions from Ligand-to-Metal Charge Transfer Excited States.
CAS:配体到金属电荷转移激发态的质子耦合电子转移反应。
- 批准号:
2400727 - 财政年份:2024
- 资助金额:
$ 20.17万 - 项目类别:
Standard Grant
STTR Phase I: Potassium Ion Battery with Intermediate Charge Rate Competes with Lithium Ferrophosphate (LFP)-based Lithium-Ion Batteries (LIBs)
STTR 第一阶段:具有中等充电速率的钾离子电池与基于磷酸铁锂 (LFP) 的锂离子电池 (LIB) 竞争
- 批准号:
2332113 - 财政年份:2024
- 资助金额:
$ 20.17万 - 项目类别:
Standard Grant
ERI: Unravel Charge Transfer Mechanisms in the Bulk and at Interphases and Interfaces of Ionogel Solid Electrolytes for High-Power-Density All-Solid-State Li Metal Batteries
ERI:揭示高功率密度全固态锂金属电池的离子凝胶固体电解质的本体以及相间和界面的电荷转移机制
- 批准号:
2347542 - 财政年份:2024
- 资助金额:
$ 20.17万 - 项目类别:
Standard Grant
Charge-Spin Conversions and Nonreciprocal Transport in Chiral Materials
手性材料中的电荷自旋转换和不可逆输运
- 批准号:
2325147 - 财政年份:2024
- 资助金额:
$ 20.17万 - 项目类别:
Standard Grant
Charge Patterning and Molecular Interactions in the Phase Behavior of Polyelectrolyte/Particle Solutions
聚电解质/颗粒溶液相行为中的电荷模式和分子相互作用
- 批准号:
2347031 - 财政年份:2024
- 资助金额:
$ 20.17万 - 项目类别:
Continuing Grant
Charge-Controlled Materials for Separations of Important Resources
用于分离重要资源的电荷控制材料
- 批准号:
DP240103089 - 财政年份:2024
- 资助金额:
$ 20.17万 - 项目类别:
Discovery Projects
Understanding the role of organic ligands on charge transport and photocurrent generation in layered perovskites
了解有机配体对层状钙钛矿中电荷传输和光电流产生的作用
- 批准号:
2892542 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Studentship
New Horizons in the Atomistic Simulation of Charge and Exciton Transport in Optoelectronic Materials
光电材料中电荷和激子输运原子模拟的新视野
- 批准号:
2868548 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Studentship
NSF-BSF: Ultrafast Laser-Electron Heating for Tailoring the Emittance and Charge of High-Energy Proton Beams
NSF-BSF:超快激光电子加热用于调整高能质子束的发射率和电荷
- 批准号:
2308860 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Standard Grant
A Component-wise Model for Understanding Spin-Charge Interactions in Nanoparticle Solids Using Targeted Synthesis, Magnetometry, and Magnetoresistance
利用靶向合成、磁力测定和磁阻来理解纳米颗粒固体中自旋电荷相互作用的组件模型
- 批准号:
2322706 - 财政年份:2023
- 资助金额:
$ 20.17万 - 项目类别:
Continuing Grant














{{item.name}}会员




